Table 1.
Summary of Cohort at Time of CD Diagnosis
| Variable | Total (n=241) |
|---|---|
| Age at CD diagnosis* | 47 (18, 84) |
| Gender | |
| . Male | 65 (27%) |
| . Female | 176 (73%) |
| Decade of CD diagnosis | |
| . 1970s | 2 (1%) |
| . 1980s | 6 (2%) |
| . 1990s | 47 (20%) |
| . 2000s | 186 (77%) |
| Clinical presentation | |
| . Classical | 157 (65%) |
| . Atypical | 76 (32%) |
| . Silent | 8 (3%) |
| Diarrhea | 157 (65%) |
| Weight loss | 109 (45%) |
| Severe CD | 87 (36%) |
| Autoimmune disease | 49 (21%) |
| Positive tTGA at CD diagnosis | 93/110 (85%) |
| tTGA titer at CD diagnosis* | 83 (20, 250) |
| Positive EMA at CD diagnosis | 89/116 (77%) |
| EMA titer at CD diagnosis* | 160 (5, 2560) |
| Positive tTGA or EMA at CD diagnosis | 126/160 (79%) |
| Intraepithelial lymphocytes at CD diagnosis* | 75 (20, 200) |
| Villous atrophy at CD diagnosis | |
| . Partial | 123 (51%) |
| . Total | 118 (49%) |
| Villous to crypt ratio at CD diagnosis* | 0.2 (0.0,2.0) |
Median (Min, Max)
CD, celiac disease; tTGA, tissue transglutaminase antibody; EMA, endomysial antibody